BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1807873)

  • 1. Platelet-activating factor acetylhydrolase in plasma lipoproteins of healthy men and women.
    Satoh K; Imaizumi T; Yoshida H; Kawamura Y; Takamatsu S; Takamatsu M; Mizuno S
    Clin Chim Acta; 1991 Oct; 202(1-2):95-103. PubMed ID: 1807873
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet-activating factor acetylhydrolase from human plasma.
    Stafforini DM; McIntyre TM; Prescott SM
    Methods Enzymol; 1990; 187():344-57. PubMed ID: 2172738
    [No Abstract]   [Full Text] [Related]  

  • 3. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions].
    Kawamura Y; Satoh K; Takamatsu S; Mizuno S
    Rinsho Byori; 1987 Oct; 35(10):1149-53. PubMed ID: 3437547
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke.
    Satoh K; Yoshida H; Imaizumi T; Takamatsu S; Mizuno S
    Stroke; 1992 Aug; 23(8):1090-2. PubMed ID: 1636183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor acetylhydrolase in human seminal plasma.
    Letendre ED; Miron P; Roberts KD; Langlais J
    Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma platelet-activating factor acetylhydrolase.
    Stafforini DM; Tjoelker LW
    Methods Mol Biol; 1999; 109():49-58. PubMed ID: 9918011
    [No Abstract]   [Full Text] [Related]  

  • 7. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
    Ostermann G; Kostner GM; Gries A; Malle E; Till U
    Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF-acetylhydrolase, predominantly present in LDL in healthy subjects, is associated with HDL in a patient with LDL deficiency.
    Surya II; Mommersteeg M; Erkelens DW; Akkerman JW
    J Lipid Mediat; 1991; 3(1):27-38. PubMed ID: 1768838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor-acetylhydrolase activity in normotensive and hypertensive pregnancies.
    Maki N; Magness RR; Miyaura S; Gant NF; Johnston JM
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):50-4. PubMed ID: 8420347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
    Stafforini DM; Carter ME; Zimmerman GA; McIntyre TM; Prescott SM
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2393-7. PubMed ID: 2928339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis.
    Shohet RV; Anwar A; Johnston JM; Cohen JC
    Am J Cardiol; 1999 Jan; 83(1):109-11, A8-9. PubMed ID: 10073795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein.
    Stafforini DM; Zimmerman GA; McIntyre TM; Prescott SM
    Trans Assoc Am Physicians; 1992; 105():44-63. PubMed ID: 1309005
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.
    Satoh K; Imaizumi T; Yoshida H; Takamatsu S
    J Lab Clin Med; 1994 Feb; 123(2):225-31. PubMed ID: 8301198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial purification and localization of platelet-activating factor acetylhydrolase from bovine seminal plasma.
    Hough SR; Parks JE
    J Androl; 1997; 18(5):540-8. PubMed ID: 9349753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
    Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H
    J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer.
    Denizot Y; Truffinet V; Bouvier S; Gainant A; Cubertafond P; Mathonnet M
    Mediators Inflamm; 2004 Feb; 13(1):53-4. PubMed ID: 15203567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum platelet-activating factor acetylhydrolase during coronary artery bypass surgery.
    Nathan N; Cornu E; Denizot Y; Feiss P; Arnoux B
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):254-5. PubMed ID: 8204819
    [No Abstract]   [Full Text] [Related]  

  • 20. The hormonal regulation of platelet-activating factor-acetylhydrolase in the rat.
    Yasuda K; Johnston JM
    Endocrinology; 1992 Feb; 130(2):708-16. PubMed ID: 1733719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.